Sanofi, Google’s Verily Enter Diabetes JV To Produce Joined Up Solutions
Sanofi’s diabetes head says French drug maker’s JV pact with Google’s Verily will combine novel therapies for the condition with cutting edge technologies to produce better focused, outcome-based combinations.